ESR1 and breast carcinoma: After estrogen binding, ESR1 translocates to the nucleus and binds to estrogen receptor elements in enhancer regions of the genome, mediating gene transcription during normal physiological processes, but also in the course of breast cancer tumorigenesis [46].